Sponsor Pipeline

Rongrong Liu Clinical Trial Pipeline

Data updated daily from ClinicalTrials.gov — last refresh 2026-08-16
2
Active Trials
2
Recruiting
1
Disease Areas
Active Trials by Phase
Phase 2
2
Active Trials
NCT IDTitleConditionStatus
Phase 2
NCT06657391 Evaluation of Recombinant Humanized Anti-CD25 Monoclonal Antibody for Preventing… Transfusion Dependent Thalassemia Recruiting
NCT07338344 Evaluating the Clinical Efficacy and Safety of Luspatercept Combined With Thalidomide in… Transfusion-dependent β-thalassemia Patients Recruiting
Disease Areas
Thalassemia (2)
Get alerts when Rongrong Liu's trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free